ClinicalTrials.Veeva

Menu

OFA - Opioid Free Anesthesia

U

University of Parma

Status and phase

Unknown
Phase 4

Conditions

Postoperative Pain

Treatments

Drug: Clonidine
Drug: Ketamine
Drug: Remifentanil
Drug: Lidocaine

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Opioids have been used for analgesia since many years, but despite potent analgesia they are also associated to side effects, including opioid induced Hyperalgesia (OIH).

OIH in the surgical setting is debated, and may predispose patients to higher analgesic consumption in the preoperative period, and peripheral and central sensitization. The aim of the study is to compare remifentanil-based vs non opioid analgesia (clonidine, lidocaine, ketamine) for intraoperative management of patients undergoing laparoscopic left hemicolectomy, with the hypothesis that non- opiod treated patients will have lower morphine consumption in the first 24 hours after surgery. Peripheral and central hyperalgesia will be tested with Von Frey hairs and pin-prick to evaluate acute CNS (Central Nervous System) sensitization after surgery. Acute and persistent (1 and 3 months) pain will be registered, together with any side effect and parameters of surgical rehabilitation.

Enrollment

64 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • left hemicolectomy
  • signed informed consent
  • >18 ys

Exclusion criteria

  • >90 ys <18 ys
  • no consent
  • pregnancy
  • psychiatric disease
  • cardiac failure, aortic or mitral valve severe stenosis
  • kidney or hepatic failure
  • atrio-ventricular type II block
  • immunodepression
  • emergency surgery
  • ICU admittance
  • drug or alcohol abuse
  • chronic pain

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

64 participants in 2 patient groups

opioid
Active Comparator group
Description:
remifentanil 0,15-0,25 mcg/kg/h
Treatment:
Drug: Remifentanil
opioid free
Experimental group
Description:
ketamine bolus 0,5 mg/kg + infusion 0,25 mg/kg/h lidocaine bolus 1 mg/kg + infusion 1 mg/kg/h clonidine 4 mcg/kg
Treatment:
Drug: Ketamine
Drug: Lidocaine
Drug: Clonidine

Trial contacts and locations

1

Loading...

Central trial contact

Bugada Dario, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems